Sangamo Therapeutics (SGMOQ) Asset Utilization Ratio (2011 - 2025)

Sangamo Therapeutics has reported Asset Utilization Ratio for 15 years, with the latest figure at 0.53 in Q4 2025.

• On a quarterly basis, Asset Utilization Ratio changed 0.0% year-over-year to 0.53 in Q4 2025; TTM through Dec 2025 was 0.53, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.49, up 13.2% from the prior year.
• Asset Utilization Ratio was 0.53 for Q4 2025 at Sangamo Therapeutics, up from 0.34 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.92 in Q4 2023, with the low at 0.11 in Q2 2024.
• Average Asset Utilization Ratio over 5 years is 0.39, with a median of 0.27 recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio slumped 80.62% in 2024, then jumped 693.74% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.15 in 2021, then gained by 29.92% to 0.19 in 2022, then jumped by 375.59% to 0.92 in 2023, then slumped by 41.77% to 0.53 in 2024, then retreated by 0.0% to 0.53 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.53 (Q4 2025), 0.34 (Q3 2025), and 0.88 (Q2 2025), per Business Quant data.